330 related articles for article (PubMed ID: 8945520)
21. Interactions of CstF-64, CstF-77, and symplekin: implications on localisation and function.
Ruepp MD; Schweingruber C; Kleinschmidt N; Schümperli D
Mol Biol Cell; 2011 Jan; 22(1):91-104. PubMed ID: 21119002
[TBL] [Abstract][Full Text] [Related]
22. B-cell and plasma-cell splicing differences: a potential role in regulated immunoglobulin RNA processing.
Bruce SR; Dingle RW; Peterson ML
RNA; 2003 Oct; 9(10):1264-73. PubMed ID: 13130140
[TBL] [Abstract][Full Text] [Related]
23. Inducible nuclear factors binding the IgM heavy chain pre-mRNA secretory poly(A) site.
Phillips C; Schimpl A; Dietrich-Goetz W; Clements JB; Virtanen A
Eur J Immunol; 1996 Dec; 26(12):3144-52. PubMed ID: 8977316
[TBL] [Abstract][Full Text] [Related]
24. Elevated levels of the 64-kDa cleavage stimulatory factor (CstF-64) in lipopolysaccharide-stimulated macrophages influence gene expression and induce alternative poly(A) site selection.
Shell SA; Hesse C; Morris SM; Milcarek C
J Biol Chem; 2005 Dec; 280(48):39950-61. PubMed ID: 16207706
[TBL] [Abstract][Full Text] [Related]
25. Regulation of poly(A) site use during mouse B-cell development involves a change in the binding of a general polyadenylation factor in a B-cell stage-specific manner.
Edwalds-Gilbert G; Milcarek C
Mol Cell Biol; 1995 Nov; 15(11):6420-9. PubMed ID: 7565794
[TBL] [Abstract][Full Text] [Related]
26. Overexpression of the CstF-64 and CPSF-160 polyadenylation protein messenger RNAs in mouse male germ cells.
Dass B; Attaya EN; Michelle Wallace A; MacDonald CC
Biol Reprod; 2001 Jun; 64(6):1722-9. PubMed ID: 11369601
[TBL] [Abstract][Full Text] [Related]
27. During B-cell differentiation enhancer activity and transcription rate of immunoglobulin heavy chain genes are high before mRNA accumulation.
Gerster T; Picard D; Schaffner W
Cell; 1986 Apr; 45(1):45-52. PubMed ID: 3082521
[TBL] [Abstract][Full Text] [Related]
28. Functional interaction of BRCA1-associated BARD1 with polyadenylation factor CstF-50.
Kleiman FE; Manley JL
Science; 1999 Sep; 285(5433):1576-9. PubMed ID: 10477523
[TBL] [Abstract][Full Text] [Related]
29. Complex protein interactions within the human polyadenylation machinery identify a novel component.
Takagaki Y; Manley JL
Mol Cell Biol; 2000 Mar; 20(5):1515-25. PubMed ID: 10669729
[TBL] [Abstract][Full Text] [Related]
30. A secondary structure at the 3' splice site affects the in vitro splicing reaction of mouse immunoglobulin mu chain pre-mRNAs.
Watakabe A; Inoue K; Sakamoto H; Shimura Y
Nucleic Acids Res; 1989 Oct; 17(20):8159-69. PubMed ID: 2510128
[TBL] [Abstract][Full Text] [Related]
31. Genome-wide analysis of pre-mRNA 3' end processing reveals a decisive role of human cleavage factor I in the regulation of 3' UTR length.
Martin G; Gruber AR; Keller W; Zavolan M
Cell Rep; 2012 Jun; 1(6):753-63. PubMed ID: 22813749
[TBL] [Abstract][Full Text] [Related]
32. An intronic polyadenylation site in human and mouse CstF-77 genes suggests an evolutionarily conserved regulatory mechanism.
Pan Z; Zhang H; Hague LK; Lee JY; Lutz CS; Tian B
Gene; 2006 Feb; 366(2):325-34. PubMed ID: 16316725
[TBL] [Abstract][Full Text] [Related]
33. Alternative processing of IgA pre-mRNA responds like IgM to alterations in the efficiency of the competing splice and cleavage-polyadenylation reactions.
Seipelt RL; Peterson ML
Mol Immunol; 1995 Mar; 32(4):277-85. PubMed ID: 7723773
[TBL] [Abstract][Full Text] [Related]
34. Transcription elongation factor ELL2 directs immunoglobulin secretion in plasma cells by stimulating altered RNA processing.
Martincic K; Alkan SA; Cheatle A; Borghesi L; Milcarek C
Nat Immunol; 2009 Oct; 10(10):1102-9. PubMed ID: 19749764
[TBL] [Abstract][Full Text] [Related]
35. Expression of the thyroid hormone receptor gene, erbAalpha, in B lymphocytes: alternative mRNA processing is independent of differentiation but correlates with antisense RNA levels.
Hastings ML; Milcarek C; Martincic K; Peterson ML; Munroe SH
Nucleic Acids Res; 1997 Nov; 25(21):4296-300. PubMed ID: 9336460
[TBL] [Abstract][Full Text] [Related]
36. Role of differential mRNA stability in the regulated expression of IgM and IgD.
Reed DJ; Hawley J; Dang T; Yuan D
J Immunol; 1994 Jun; 152(11):5330-6. PubMed ID: 8189050
[TBL] [Abstract][Full Text] [Related]
37. Anti-IgM treatment influences immunoglobulin heavy and light chain mRNA levels in mitogen-stimulated B lymphocytes.
Leanderson T; Hsu E
Eur J Immunol; 1985 Jun; 15(6):641-3. PubMed ID: 3924632
[TBL] [Abstract][Full Text] [Related]
38. The C-terminal domain of RNA polymerase II couples mRNA processing to transcription.
McCracken S; Fong N; Yankulov K; Ballantyne S; Pan G; Greenblatt J; Patterson SD; Wickens M; Bentley DL
Nature; 1997 Jan; 385(6614):357-61. PubMed ID: 9002523
[TBL] [Abstract][Full Text] [Related]
39. B cell response pathways regulated by IL-5 and IL-2. Secretory microH chain-mRNA and J chain mRNA expression are separately controlled events.
Matsui K; Nakanishi K; Cohen DI; Hada T; Furuyama J; Hamaoka T; Higashino K
J Immunol; 1989 Apr; 142(8):2918-23. PubMed ID: 2495329
[TBL] [Abstract][Full Text] [Related]
40. The gene for a variant form of the polyadenylation protein CstF-64 is on chromosome 19 and is expressed in pachytene spermatocytes in mice.
Dass B; McMahon KW; Jenkins NA; Gilbert DJ; Copeland NG; MacDonald CC
J Biol Chem; 2001 Mar; 276(11):8044-50. PubMed ID: 11113135
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
